ZYDUS WELLNESS LTD.-$ - 531335 - Receipt Of Demand Cum Penalty Order From GST Authority
Receipt of Demand cum Penalty order from GST Authority08-12-2023
08-12-2023
Zydus Lifesciences receives approval for methylene blue injection
Zydus Lifesciences stock rises 0.61% to 637.9006-12-2023
Zydus Life gains on USFDA nod for heart drug
Zydus Lifesciences may be eligible for 180 days of shared generic exclusivity for Ivabradine tablets which reduce the risk of hospitalisation for worsening heart failure in adult patients01-12-2023
Torrent and Zydus sign pact to co-market Saroglitazar for chronic liver diseases in India
Torrent will pay Zydus upfront licensing fees and milestone payments based on the achievement of pre-defined milestones10-11-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Q2 2023-24 Earnings Conference call held on November 6, 202310-11-2023
Buy Zydus Wellness; target of Rs 1800: ICICI Securities
ICICI Securities is bullish on Zydus Wellness recommended buy rating on the stock with a target price of Rs 1800 in its research report dated November 07, 2023.09-11-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication with regard to unaudited financial results for the quarter and half year ended on September 30, 202307-11-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of the Investor Call on unaudited financial results for the quarter and half year ended on September 30, 202306-11-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Revised press release on unaudited financial results for the quarter and half year ended on September 30, 202306-11-2023